These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7078464)
1. MDPH goes after statistics of mild, as well as severe, vaccine reactions. Berlin BS Mich Med; 1982 Feb; 81(8):100, 102. PubMed ID: 7078464 [No Abstract] [Full Text] [Related]
6. The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry. Robertson SE; Mayans MV; Horsfall S; Wright PF; Clemens J; Ivanoff B; Lambert PH Bull World Health Organ; 1997; 75(4):295-305. PubMed ID: 9342888 [TBL] [Abstract][Full Text] [Related]
7. Dermal testing of vaccines for children at high risk of allergies. Sugai K; Shiga A; Okada K; Iwata T; Ogura H; Maekawa K; Yokota S Vaccine; 2007 Apr; 25(17):3454-63. PubMed ID: 17276555 [TBL] [Abstract][Full Text] [Related]
8. Michigan's vaccine for children program expands its coverage. Michigan Department of Community Health Mich Med; 2007; 106(4):25. PubMed ID: 17710866 [No Abstract] [Full Text] [Related]
9. The nature and consequences of intra- and inter-vaccine interference. Vidor E J Comp Pathol; 2007 Jul; 137 Suppl 1():S62-6. PubMed ID: 17560593 [TBL] [Abstract][Full Text] [Related]
10. An immunization update for primary health care providers. Osguthorpe NC; Morgan EP Nurse Pract; 1995 Jun; 20(6):52-4, 64-5. PubMed ID: 7659320 [TBL] [Abstract][Full Text] [Related]
11. Pediatric hypertension risk reduction: a city-county-state cooperative effort in Wayne County, Michigan. Brathwaite D; Gadsden L; McKinney C; Tripp J Urban Health; 1984 Apr; 13(3):21-3, 49-50. PubMed ID: 10266328 [No Abstract] [Full Text] [Related]
13. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):94-7. PubMed ID: 11263794 [TBL] [Abstract][Full Text] [Related]
14. The MDPH challenge. Carlyn M Mich Hosp; 1986 May; 22(5):17-21. PubMed ID: 10276922 [No Abstract] [Full Text] [Related]
15. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999. Geier DA; Geier MR Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752 [TBL] [Abstract][Full Text] [Related]
16. Safety considerations for new vaccine development. Ellenberg SS Pharmacoepidemiol Drug Saf; 2001; 10(5):411-5. PubMed ID: 11802587 [TBL] [Abstract][Full Text] [Related]
17. An update on vaccine safety. Zimmerman RK; Kimmel SR; Trauth JM Am Fam Physician; 1996 Jul; 54(1):185-93. PubMed ID: 8677834 [TBL] [Abstract][Full Text] [Related]
18. Vaccine safety perceptions and experience with adverse events following immunization in Uzbekistan. Fowler GL; Weintraub E; Kennedy A; Luman ET; Shui I; Khromava A; Kohl K; Gust DA Public Health; 2008 Apr; 122(4):412-6. PubMed ID: 17961615 [No Abstract] [Full Text] [Related]
19. Vaccine risk/benefit communication: effect of an educational package for public health nurses. Davis TC; Fredrickson DD; Kennen EM; Humiston SG; Arnold CL; Quinlin MS; Bocchini JA Health Educ Behav; 2006 Dec; 33(6):787-801. PubMed ID: 16861585 [TBL] [Abstract][Full Text] [Related]
20. Standards for child and adolescent immunization practices. National Vaccine Advisory Committee. National Vaccine Advisory Committee Pediatrics; 2003 Oct; 112(4):958-63. PubMed ID: 14523192 [No Abstract] [Full Text] [Related] [Next] [New Search]